Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in Chronic Kidney Disease
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
MHEF 2023: Muscle-Bone Health Education Forum
Join us at the Musculoskeletal Health Education Forum 2023, an event dedicated to “Building Musculoskeletal Resiliency.”
Taking place on September 30th, this forum promises a day brimming with invaluable insights and opportunities to enhance your understanding and capacity in the field of musculoskeletal health.
Whether you’re a healthcare professional, researcher, or simply someone passionate about musculoskeletal well-being, this event is designed to equip you with the latest knowledge and tools to foster resiliency in this vital area of health. Expect to be surrounded by esteemed experts and like-minded individuals who share a common goal of advancing musculoskeletal health! The Musculoskeletal Health Education Forum 2023 provides an ideal platform to network, exchange ideas, and engage in meaningful conversations that can shape the future of musculoskeletal health.
When is this event taking place?Â
September 30, 2023
Where is this event taking place?
Brock University, St. Catherine’s, Ontario, Canada
Read more about Science!
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology View Paper Here
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways View Paper
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in BCMA CAR-NK Therapy
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB and its downstream factors
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders